Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases

Completed

Conditions studied: Breast Cancer

In brief

The objective of this pilot study is to develop and evaluate a whole body MRI technique for detecting cancer metastases. The whole body MRI will include T1-weighted and T2-weighted phase-sensitive MR imaging as well as diffusion weighted imaging of the whole body in multiple patient table stations.

Key facts

Study ID

NCT00592462

Run by

M.D. Anderson Cancer Center

People needed

32

Starts

2007-12-01

Expected to finish

2015-12-01

Last updated by the study team

2016-10-27

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Breast cancer patients with high suspicion or confirmed bone metastases.
• Patient who have undergone a clinically indicated skeletal scintigraphy within two weeks of the MRI exam.
• Patients who have signed their informed consent form to undergo the study.

You may not qualify if…

• Contraindication to conventional MR imaging (e.g. metal implants, pace maker, etc.).

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.